ACE2 enhances the drug sensitivity of tumor cells through the Mas‐mediated signaling pathway, and may also inhibit the proliferation, metastasis, invasion, and angiogenesis of various tumor cells such as breast cancer, colon cancer, and lung cancer through other pathways [9]. This evidence concerns the gene ACE2 and breast carcinoma.